Jade Biosciences, Inc. Common Stock JBIO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$127.41M-46.4% | -$87.03M-15.2% | -$75.52M-46.6% | -$51.51M-124% | ||
| $26K-90.8% | $282K+194% | $96K+41.2% | $68K+353% | ||
| $20.01M+114% | $9.35M-21.5% | $11.91M+117% | $5.48M+168% | ||
| -$94.69M-78.4% | -$53.09M+6.5% | -$56.78M-45.1% | -$39.12M-42.8% | ||
| $196K— | —— | $142K-27.2% | $195K+7.7% | ||
| -$247.01M-1,225% | $21.96M— | —— | —— | ||
| $360.77M+92.7% | $187.24M+307% | $46M— | —— | ||
| $19.05M-86.7% | $142.99M— | —— | -$31.8M— | ||
| -$94.89M— | —— | -$56.92M-44.8% | -$39.32M-42.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jade Biosciences, Inc. Common Stock generate?
- Jade Biosciences, Inc. Common Stock (JBIO) generated -$100.0M in operating cash flow over the trailing twelve months.
- What is Jade Biosciences, Inc. Common Stock's free cash flow?
- After $196.0K of capital expenditures, Jade Biosciences, Inc. Common Stock's free cash flow was -$94.9M over the trailing twelve months, down 66.7% year over year.
- Where does Jade Biosciences, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Jade Biosciences, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.